Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT07634640
NCT07634640RecruitingPhase 1

Omega-3 Fatty Acids and Myocardial Inflammation in HFpEF: Preliminary Data and Next Steps

University of Florida1 site in 1 country70 target enrollmentStarted: November 3, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Enrollment
70
Locations
1
Study OverviewStudy DesignEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Renal insufficiency

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 1
Novel Approach to Increase EPA and DHA Levels
NCT07304921Riga Stradins University48
Not yet recruiting
Phase 3
Trial on effectiveness of omega-3 fatty acid supplements compared to Steroids in treating Lichen Planus of mouth
CTRI/2024/11/076144Medona Antony42
Recruiting
Not Applicable
Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression
NCT07363551China Medical University Hospital60
Recruiting
Not Applicable
A study to assess the predictive value of simple blood count marker versus advanced cytokine biomarker for outcomes in off-pump coronary artery bypass surgery
CTRI/2025/03/081887DR SARAH IQBAL80
Completed
Not Applicable
Mobile App for CAD patients to assess the effect on medication adherence, diet compliance. physical activity and self care
CTRI/2025/04/084053Neeraj158